China Isotope & Radiation Corporation (1763.HK) HKSE

15.89

-0.51(-3.11%)

Updated at September 26 04:08PM

Currency In HKD

China Isotope & Radiation Corporation

Address

No. 66 Changwa Middle Street

Beijing,

China

Phone

86 10 6841 1265

Sector

Healthcare

Industry

Medical - Devices

Employees

3367

First IPO Date

July 06, 2018

Key Executives

NameTitlePayYear Born
Ms. Yingying HuoExecutive Director146,3181983
Mr. Jin DuChief Engineer1.2M1966
Mr. Junqi ZhangGM & Executive Director1.22M1972
Mr. Yongjiang HanExecutive Chairman01983
Ms. Cangren WangChief Accountant, Joint Secretary & General Legal Counsel01977
Ms. Sau In KwanJoint Secretary0N/A

Description

China Isotope & Radiation Corporation engages in the research and development, manufacture, and sale of diagnostic and therapeutic radiopharmaceuticals and radioactive source products for medical and industrial applications in China. It operates through five segments: Pharmaceuticals; Radioactive Source Products; Irradiation; Radiation Therapy Equipment and Related Services; and Independent Clinical Medical and Laboratory Services, and Other Business. The Pharmaceuticals segment engages in the research, development, manufacture, and sale of imaging diagnostic and therapeutic radiopharmaceuticals; UBT kits and analyzers; and in vitro immunoassay diagnostic reagents and kits. The Radioactive Source Products segment provides medical and industrial radioactive sources products and related technical services. The Irradiation segment offers irradiation services to manufacturers of medical devices, food, traditional Chinese medicine, and cosmetics for sterilization; and EPC services for the design, manufacturing, and installation of gamma ray irradiation facilities. The Radiation Therapy Equipment and Related Services segment sells radiation therapy equipment; and provides related maintenance services. The Independent Clinical Medical and Laboratory Services, and Other Business segment provides independent clinical laboratory services with respect to hepatitis, endocrine, bone metabolism, cardiovascular disease, diabetes, and other diseases to hospitals and other medical institutions. The company was founded in 1983 and is headquartered in Beijing, China. China Isotope & Radiation Corporation is a subsidiary of China National Nuclear Corporation.